Skip to main content
August 18, 2022
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Home
Myelodysplastic Syndrome
Myelodysplastic Syndrome
Myelodysplastic Syndrome
Overview of Myelodysplastic Syndrome
By CancerConnect
Jun 29, 2022
Myelodysplastic Syndrome
Dacogen™ Effective in Myelodysplastic Syndromes
By Dr. C.H. Weaver M.D.
Jun 10, 2022
Myelodysplastic Syndrome
Reblozyl® Approved to Treat Anemia for Lower-Risk Myelodysplastic Syndromes
By MedMaven
Mar 20, 2022
Myelodysplastic Syndrome
Treatment of Myelodysplastic Syndrome
By Dr. C.H. Weaver M.D.
Jan 26, 2022
Myelodysplastic Syndrome
Stem Cell Transplant - Successful Treatment for Myelodysplastic Syndromes
By Dr. C.H. Weaver M.D.
May 25, 2021
Myelodysplastic Syndrome
Magrolimab Anti-CD47 Monoclonal Antibody
By MedMaven
Dec 5, 2020
Myelodysplastic Syndrome
Inqovi (cedazuridine) Treatment for Myelodysplastic Syndromes and CMML
By MedMaven
Jul 22, 2020
Myelodysplastic Syndrome
Guadecitabine Treatment for Myelodysplastic Syndromes
By MedMaven
Jul 30, 2019
Myelodysplastic Syndrome
The CancerConnect Myelodysplastic Syndrome Newsletter
By TraceyS
Feb 13, 2019
Myelodysplastic Syndrome
Revlimid® Reduces Need for Blood Transfusions in Some Myelodysplastic Syndromes
By CancerConnect
Aug 2, 2018
Myelodysplastic Syndrome
Novel Agent may Reverse Resistance to Targeted Therapy in Acute Leukemia and MDS
By CancerConnect
Jul 26, 2018
Myelodysplastic Syndrome
Vidaza® Improves Survival in Higher-risk Myelodysplastic Syndromes
By CancerConnect
Jul 20, 2018
Myelodysplastic Syndrome
Vidaza® Approved for High-risk MDS
By CancerConnect
Jun 30, 2018
Myelodysplastic Syndrome
Vidaza Improves Survival in High-risk Myelodysplastic Syndrome
By CancerConnect
Jun 20, 2018
Myelodysplastic Syndrome
Mylotarg® and Vidaza® Effective for Elderly Patients with AML or MDS
By CancerConnect
Jun 20, 2018
Myelodysplastic Syndrome
Revlimid® Shows Promise in Treatment of Myelofibrosis with Myeloid Metaplasia
By CancerConnect
Jun 9, 2018
Myelodysplastic Syndrome
Updates in the Management of Myelodysplastic Syndromes
By CancerConnect
Jun 6, 2018
Myelodysplastic Syndrome
Vidaza® Improves Survival in Myelodysplastic Syndromes
By CancerConnect
Jun 2, 2018
Myelodysplastic Syndrome
Revlimid® Effective for Patients with Myelodysplastic Syndromes with Deletion
By CancerConnect
Jun 1, 2018
Myelodysplastic Syndrome
AMG 531 May Be Effective in Treating Thrombocytopenia in Patients with MDS
By CancerConnect
Jun 1, 2018
Myelodysplastic Syndrome
Erythropoietin Plus Granulocyte Macrophage Factor for Myelodysplastic Syndrome
By CancerConnect
Oct 31, 2017
Myelodysplastic Syndrome
Anti-Inflammatory Drug Combination Appears to Improve Blood Counts for Persons
By CancerConnect
Dec 20, 2016
Myelodysplastic Syndrome
Aggressive Chemotherapy Increases Remission in Patients with High-Risk MDS
By CancerConnect
Jan 13, 2015
Myelodysplastic Syndrome
Autologous Stem Cell Transplants Prove Promising in Myelodysplastic Syndromes
By CancerConnect
Mar 11, 2009
Myelodysplastic Syndrome
Further Evidence that Vidaza® Reduces Need for Transfusions in MDS
By CancerConnect
Mar 8, 2009
Myelodysplastic Syndrome
Revlimid® Approved for Myelodysplastic Syndromes
By CancerConnect
Mar 8, 2009
Myelodysplastic Syndrome
Thalidomide Effective for Myelodysplastic Syndrome
By CancerConnect
Mar 8, 2009
Myelodysplastic Syndrome
Revlimid™ Effective for Low-Risk Myelodysplastic Syndromes
By CancerConnect
Mar 8, 2009
Myelodysplastic Syndrome
Prospective Study Shows Age Doesn’t Affect Survival Outcomes in Patients
By CancerConnect
Mar 8, 2009
Myelodysplastic Syndrome
Prolonged Erythropoietin Appears More Effective Than Short Course for MDS
By CancerConnect
Mar 8, 2009
Myelodysplastic Syndrome
Revlimid® Shows Promise for Myelodysplastic Syndromes
By CancerConnect
Nov 13, 2007
Myelodysplastic Syndrome
Thalidomide Promising for Myelodysplastic Syndromes
By CancerConnect
Oct 24, 2006
CLOSE
CLOSE
CLOSE
CLOSE